Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
API
0
FDF
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
ABOUT THIS PAGE
Severity: Warning
Message: include(../assets/text/seoInfo/73456806.txt): Failed to open stream: No such file or directory
Filename: include/seoInfo.php
Line Number: 77
Backtrace:
File: /var/www/html/application/views/include/seoInfo.php
Line: 77
Function: _error_handler
File: /var/www/html/application/views/include/seoInfo.php
Line: 77
Function: include
File: /var/www/html/application/views/include/product/indexNew.php
Line: 1266
Function: include
File: /var/www/html/application/views/commonNew.php
Line: 442
Function: include
File: /var/www/html/application/controllers/Search.php
Line: 1720
Function: view
File: /var/www/html/index.php
Line: 224
Function: require_once
Severity: Warning
Message: include(): Failed opening '../assets/text/seoInfo/73456806.txt' for inclusion (include_path='.:/usr/share/pear:/usr/share/php')
Filename: include/seoInfo.php
Line Number: 77
Backtrace:
File: /var/www/html/application/views/include/seoInfo.php
Line: 77
Function: _error_handler
File: /var/www/html/application/views/include/seoInfo.php
Line: 77
Function: include
File: /var/www/html/application/views/include/product/indexNew.php
Line: 1266
Function: include
File: /var/www/html/application/views/commonNew.php
Line: 442
Function: include
File: /var/www/html/application/controllers/Search.php
Line: 1720
Function: view
File: /var/www/html/index.php
Line: 224
Function: require_once
A Leuprolide Mesylate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Leuprolide Mesylate, including repackagers and relabelers. The FDA regulates Leuprolide Mesylate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Leuprolide Mesylate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Leuprolide Mesylate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Leuprolide Mesylate supplier is an individual or a company that provides Leuprolide Mesylate active pharmaceutical ingredient (API) or Leuprolide Mesylate finished formulations upon request. The Leuprolide Mesylate suppliers may include Leuprolide Mesylate API manufacturers, exporters, distributors and traders.
click here to find a list of Leuprolide Mesylate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Leuprolide Mesylate DMF (Drug Master File) is a document detailing the whole manufacturing process of Leuprolide Mesylate active pharmaceutical ingredient (API) in detail. Different forms of Leuprolide Mesylate DMFs exist exist since differing nations have different regulations, such as Leuprolide Mesylate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Leuprolide Mesylate DMF submitted to regulatory agencies in the US is known as a USDMF. Leuprolide Mesylate USDMF includes data on Leuprolide Mesylate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Leuprolide Mesylate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Leuprolide Mesylate suppliers with USDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Leuprolide Mesylate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Leuprolide Mesylate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Leuprolide Mesylate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Leuprolide Mesylate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Leuprolide Mesylate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Leuprolide Mesylate suppliers with NDC on PharmaCompass.
Leuprolide Mesylate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Leuprolide Mesylate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Leuprolide Mesylate GMP manufacturer or Leuprolide Mesylate GMP API supplier for your needs.
A Leuprolide Mesylate CoA (Certificate of Analysis) is a formal document that attests to Leuprolide Mesylate's compliance with Leuprolide Mesylate specifications and serves as a tool for batch-level quality control.
Leuprolide Mesylate CoA mostly includes findings from lab analyses of a specific batch. For each Leuprolide Mesylate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Leuprolide Mesylate may be tested according to a variety of international standards, such as European Pharmacopoeia (Leuprolide Mesylate EP), Leuprolide Mesylate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Leuprolide Mesylate USP).
LOOKING FOR A SUPPLIER?
